Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 10/20 | 0.47 |
| ▸ | CA2 | P00918 | 10/20 | 0.47 |
| ▸ | CA9 | Q16790 | 9/20 | 0.47 |
| ▸ | CA12 | O43570 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 3/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL345885 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL5015857 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL6061185 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL8085071 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4193998 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL2194649 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10731635 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL10725263 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL3088278 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL812482 | 1.00 | RECQL (0.50) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 154 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111100227-B | Propylene polymerization method and device | 中国石油化工股份有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-111100227-A | Propylene polymerization method and device | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-109867815-A | The method that ultralight paper pulp foam high-elastic, fire prevention is water-fast is prepared using lignocellulose raw material | 中国科学院青岛生物能源与过程研究所 | 2019-06-11 | — | — | CN | claimed |
| CN-109777138-A | The method that fire protection flame retarding, ultralight high-strength paper pulp foam are prepared using lignocellulose raw material | 中国科学院青岛生物能源与过程研究所 | 2019-05-21 | — | — | CN | claimed |
| US-20150086976-A1 | SELF-CATALYTIC REACTION BASED ASSAY | UTAH STATE UNIVERSITY (US) | 2015-03-26 | — | — | US | claimed |
| US-20130216723-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2013-08-22 | — | — | US | claimed |
| EP-2203519-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | King Industries (US) | 2010-07-07 | — | — | EP | claimed |
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | KING INDUSTRIES | 2009-04-23 | — | — | US | claimed |
| WO-2009045466-A1 | SULFONATE ESTERS AS LATENT ACID CATALYSTS | KING INDUSTRIES (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2008147472-A1 | ETHERS OF BISANHYDROHEXITOLS | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2008-12-04 | — | — | WO | claimed |
| US-20080021209-A1 | Ethers of bisanhydrohexitols | NEW JERSEY INSTITUTE OF TECHNOLOGY (US) | 2008-01-24 | — | — | US | claimed |
| US-7001973-B2 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2006-02-21 | — | — | US | claimed |
| CN-1147510-C | Conditioning/styling terpolymers | ISP投资有限公司 | 2004-04-28 | — | — | CN | claimed |
| WO-2000014176-A1 | PIPERIDINE ANTIOXIDANTS AND COMPOSITIONS THEREWITH FOR PREVENTING THE FADING OF ARTIFICIAL HAIR DYE | ISP INVESTMENTS INC. (US) | 2000-03-16 | — | — | WO | claimed |
| US-5922310-A | Compositions for preventing the fading of artificial hair dye | ISP INVESTMENTS INC. (US) | 1999-07-13 | — | — | US | claimed |
| EP-4464685-B1 | PROCESS FOR PREPARING 17-METHYLALKANE COMPOUND | SHINETSU CHEMICAL CO (JP) | 2026-02-04 | — | — | EP | disclosed |
| CN-120053361-A | Hydrogel loaded with cyclodextrin aggregate as well as preparation method and application thereof | 山东大学 | 2025-05-30 | — | — | CN | disclosed |
| EP-0165710-A1 | Benzene sulfonate quaternary ammonium salts of organic sunscreen carboxylic acids | VAN DYK & COMPANY, INC. (US) | 1985-12-27 | — | — | EP | disclosed |
| EP-0157415-A2 | Pyrazolo[4,3-d] pyrimidine derivative process for its production antihyperlipidemic agent containing it, its intermediate, and process for the production of the intermediate | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1985-10-09 | — | — | EP | disclosed |
| US-4061730-A | 4-((2-OXO-BORNYLIDENE)METHYL)-PHENYL TRIALKYLAMMONIUM SALTS | SOCIETE ANONYME DITE: L'OREAL (FR) | 1977-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090104363-A1 | Sulfonate esters as latent acid catalysts | ORAI1, SARAF, NAPA | RECQL 2770/4885GLA 397/4885HPGD 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.